Tetra is a pharmaceutical drug development company developing medicines for Alzheimer's Disease, Tra
Phone: +1 616-224-0084
Total raised: $12M
Founded date: 2010
Investors 1
| Date | Name | Website |
| - | Dolby Fami... | dolbyventu... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 30.11.2016 | Series A | $10M | - |
| 03.09.2015 | - | $1M | - |
| 30.09.2013 | Seed | $1M | - |
Mentions in press and media 9
| Date | Title | Description |
| 01.05.2019 | Company starts Phase II study of Alzheimer’s drug – and it’s not going after amyloid beta | The trial, PICASSO AD, is a randomized, double-blind, placebo-controlled study designed to enroll about 255 patients aged 55-85 at up to 60 sites across the US. The three-month trial use change from baseline scores in standardized clinical ... |
| 30.11.2016 | Tetra Discovery Raises $10M Series A, Advances Alzheimer’s Drug | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Alzheimer’s drug research has been a fraught area of medicine lately. With last week’s failure of Eli Lilly’s high-profile Phase 3 study of solanezumab, an experimental Alzhei... |
| 30.11.2016 | Term Sheet — Wednesday, November 30 | ET CETERA • Startups in India: Accel has raised $450 million for its fifth India fund, a sizable jump over its $305 million fourth fund that was announced just last year. The raise comes at an uncertain time for Indian startups, which don’t... |
| 30.11.2016 | Tetra Discovery Partners Closes $7.27M Series A | GRAND RAPIDS, MI, Drug developer Tetra Discovery Partners has closed on $5 million in new venture capital funding. >> Click here for more funding data on Tetra Discovery Partners >> To export Tetra Discovery Partners funding... |
| 29.11.2016 | Tetra Discovery Partners Raises $5M in Series A Funding | Tetra Discovery Partners, a Grand Rapids, Mich.-based clinical stage biotechnology company, raised $5m in Series A venture funding. The round was co-led by the Apjohn Group and Grand Angels, with participation from previous investors as wel... |
| 03.09.2015 | Tetra Discovery Partners Closes $1M Funding Round | Tetra Discovery Partners, a Grand Rapids MI-based pharmaceutical startup developing treatments for memory loss and cognitive impairment, closed $1m funding round. The round was led by Grand Angels Fund II with participation from Invest Mich... |
| 16.10.2014 | Tetra Discovery Partners Raises Financing | Tetra Discovery Partners, a Grand Rapids, Michigan-based drug discovery company developing a portfolio of drugs for psychiatric, neurological and inflammatory diseases, raised an additional financing of undisclosed amount. Backers included ... |
| 30.09.2013 | Tetra Discovery Partners Closes $1M Seed Round | Tetra Discovery Partners, a Grand Rapids, Mich.-based designer of new therapeutics for major neurological conditions based on PDE4 modulation in the brain, closed a $1,041,000 seed funding round. The investment, which was led by Grand Angel... |
| - | Company starts Phase II study of Alzheimer’s drug – and it’s not going after amyloid beta | With several high-profile failures of Alzheimer’s disease drugs over the last several years – most recently Biogen and Eisai’s aducanumab – some firms have been looking for alternatives to the amyloid beta plaques that most of the field has... |